SCHEMBL2907176 — predicted protein targets

Known targets — ChEMBL curated mechanism

ABL1 BMX BRAF BTK CHRNA4 CHRNB2 CSNK1E EGFR ERBB2 F10 FLT1 FLT3 FLT4 IGF1R INSR ITK JAK3 KDR KIT OPRM1 PARP1 PARP2 PDGFRB PIK3CD RAF1 RET SLC18A2 TEC TXK dacA dacB dacC ftsI mrcA mrcB mrdA rplA rplB rplC rplD rplE rplF rplJ rplK rplL rplM rplN rplO rplP rplQ rplR rplS rplT rplU rplV rplW rplX rplY rpmA rpmB rpmC rpmD rpmE rpmF rpmG rpmH rpmI rpmJ rpsA rpsB rpsC rpsD rpsE rpsF rpsG rpsH rpsI rpsJ rpsK rpsL rpsM rpsN rpsO rpsP rpsQ rpsR rpsS rpsT rpsU ykgM ykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

	gene	UniProt	supporting neighbours	confidence
▸	F10 known ✓	P00742	1/20	0.35

▸	HTR2C	P28335	3/20	0.34

▸	HTR2B	P41595	3/20	0.34

▸	HTR2A	P28223	1/20	0.34

▸	PNMT	P11086	4/20	0.33

▸	CYP2D6	P10635	3/20	0.33

▸	NMT1	P30419	2/20	0.33

▸	LMNA	P02545	2/20	0.33

▸	CYP2C19	P33261	2/20	0.33

▸	PSEN1	P49768	2/20	0.32

▸	PSEN2	P49810	2/20	0.32

▸	APH1B	Q8WW43	2/20	0.32

▸	NCSTN	Q92542	2/20	0.32

▸	APH1A	Q96BI3	2/20	0.32

▸	PSENEN	Q9NZ42	2/20	0.32

▸	KDM4E	B2RXH2	2/20	0.32

▸	ALDH1A1	P00352	1/20	0.32

▸	MAPT	P10636	1/20	0.32

▸	HTT	P42858	1/20	0.32

▸	SMN1; SMN2	Q16637	1/20	0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL2910741	1.00	F10 (0.35)	F10HTR2CHTR2BHTR2APNMT
Bromide SCHEMBL2910613	0.84	HTR2C (0.36)	HTR2CHTR2BHTR2ASMN1; SMN2
Bromide SCHEMBL2912242	0.84	HTR2C (0.36)	HTR2CHTR2BHTR2ASMN1; SMN2
SCHEMBL2909831	0.80	HTR2C (0.41)	F10HTR2CHTR2BHTR2APNMT
Hydrochloric Acid SCHEMBL2908620	0.74	CYP3A4 (0.37)	HTR2CHTR2BHTR2APNMTSMN1; SMN2
SCHEMBL2910717	0.72	CYP2D6 (0.36)	F10HTR2CHTR2BHTR2APNMT
SCHEMBL2904273	0.71	CYP2D6 (0.35)	F10HTR2CHTR2BHTR2APNMT
SCHEMBL2912426	0.68	HTR2C (0.36)	HTR2CHTR2BHTR2ASMN1; SMN2
SCHEMBL16210108	0.68	CYP3A4 (0.41)	HTR2CPNMTSMN1; SMN2ADRA2AADRA2B
Hydrochloric Acid SCHEMBL2907934	0.67	HTR2C (0.42)	HTR2CHTR2BHTR2APNMTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-2789338-A2	Condensed pyridine derivate and use thereof	Takeda Pharmaceutical Company Limited (JP)	2014-10-15	—	—	EP	disclosed
US-20100266504-A1	CONDENSED PYRIDINE DERIVATIVE AND USE THEREOF	TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP)	2010-10-21	—	—	US	disclosed
EP-2216023-A1	CONDENSED PYRIDINE DERIVATIVE AND USE THEREOF	Takeda Pharmaceutical Company Limited (JP)	2010-08-11	—	—	EP	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20100266504-A1	CONDENSED PYRIDINE DERIVATIVE AND USE THEREOF	HTR2C, HTR5A, HTR3C	F10 3030/4885HTR2C 1/4885HTR2B 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.